Cargando…
Mortality in Pharmacologically Treated Older Adults with Diabetes: The Cardiovascular Health Study, 1989–2001
BACKGROUND: Diabetes mellitus (DM) confers an increased risk of mortality in young and middle-aged individuals and in women. It is uncertain, however, whether excess DM mortality continues beyond age 75 years, is related to type of hypoglycemic therapy, and whether women continue to be disproportion...
Autores principales: | , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1609124/ https://www.ncbi.nlm.nih.gov/pubmed/17048978 http://dx.doi.org/10.1371/journal.pmed.0030400 |
_version_ | 1782130467641753600 |
---|---|
author | Kronmal, Richard A Barzilay, Joshua I Smith, Nicholas L Psaty, Bruce M Kuller, Lewis H Burke, Gregory L Furberg, Curt |
author_facet | Kronmal, Richard A Barzilay, Joshua I Smith, Nicholas L Psaty, Bruce M Kuller, Lewis H Burke, Gregory L Furberg, Curt |
author_sort | Kronmal, Richard A |
collection | PubMed |
description | BACKGROUND: Diabetes mellitus (DM) confers an increased risk of mortality in young and middle-aged individuals and in women. It is uncertain, however, whether excess DM mortality continues beyond age 75 years, is related to type of hypoglycemic therapy, and whether women continue to be disproportionately affected by DM into older age. METHODS AND FINDINGS: From the Cardiovascular Health Study, a prospective study of 5,888 adults, we examined 5,372 participants aged 65 y or above without DM (91.2%), 322 with DM treated with oral hypoglycemic agents (OHGAs) (5.5%), and 194 with DM treated with insulin (3.3%). Participants were followed (1989–2001) for total, cardiovascular disease (CVD), coronary heart disease (CHD), and non-CVD/noncancer mortality. Compared with non-DM participants, those treated with OHGAs or insulin had adjusted hazard ratios (HRs) for total mortality of 1.33 (95% confidence interval [CI], 1.10 to 1.62) and 2.04 (95% CI, 1.62 to 2.57); CVD mortality, 1.99 (95% CI, 1.54 to 2.57) and 2.16 (95% CI, 1.54 to 3.03); CHD mortality, 2.47 (95% CI, 1.89 to 3.24) and 2.75 (95% CI, 1.95 to 3.87); and infectious and renal mortality, 1.35 (95% CI, 0.70 to 2.59) and 6.55 (95% CI, 4.18 to 10.26), respectively. The interaction of age (65–74 y versus ≥75 y) with DM was not significant. Women treated with OHGAs had a similar HR for total mortality to men, but a higher HR when treated with insulin. CONCLUSIONS: DM mortality risk remains high among older adults in the current era of medical care. Mortality risk and type of mortality differ between OHGA and insulin treatment. Women treated with insulin therapy have an especially high mortality risk. Given the high absolute CVD mortality in older people, those with DM warrant aggressive CVD risk factor reduction. |
format | Text |
id | pubmed-1609124 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2006 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-16091242006-10-17 Mortality in Pharmacologically Treated Older Adults with Diabetes: The Cardiovascular Health Study, 1989–2001 Kronmal, Richard A Barzilay, Joshua I Smith, Nicholas L Psaty, Bruce M Kuller, Lewis H Burke, Gregory L Furberg, Curt PLoS Med Research Article BACKGROUND: Diabetes mellitus (DM) confers an increased risk of mortality in young and middle-aged individuals and in women. It is uncertain, however, whether excess DM mortality continues beyond age 75 years, is related to type of hypoglycemic therapy, and whether women continue to be disproportionately affected by DM into older age. METHODS AND FINDINGS: From the Cardiovascular Health Study, a prospective study of 5,888 adults, we examined 5,372 participants aged 65 y or above without DM (91.2%), 322 with DM treated with oral hypoglycemic agents (OHGAs) (5.5%), and 194 with DM treated with insulin (3.3%). Participants were followed (1989–2001) for total, cardiovascular disease (CVD), coronary heart disease (CHD), and non-CVD/noncancer mortality. Compared with non-DM participants, those treated with OHGAs or insulin had adjusted hazard ratios (HRs) for total mortality of 1.33 (95% confidence interval [CI], 1.10 to 1.62) and 2.04 (95% CI, 1.62 to 2.57); CVD mortality, 1.99 (95% CI, 1.54 to 2.57) and 2.16 (95% CI, 1.54 to 3.03); CHD mortality, 2.47 (95% CI, 1.89 to 3.24) and 2.75 (95% CI, 1.95 to 3.87); and infectious and renal mortality, 1.35 (95% CI, 0.70 to 2.59) and 6.55 (95% CI, 4.18 to 10.26), respectively. The interaction of age (65–74 y versus ≥75 y) with DM was not significant. Women treated with OHGAs had a similar HR for total mortality to men, but a higher HR when treated with insulin. CONCLUSIONS: DM mortality risk remains high among older adults in the current era of medical care. Mortality risk and type of mortality differ between OHGA and insulin treatment. Women treated with insulin therapy have an especially high mortality risk. Given the high absolute CVD mortality in older people, those with DM warrant aggressive CVD risk factor reduction. Public Library of Science 2006-10 2006-10-17 /pmc/articles/PMC1609124/ /pubmed/17048978 http://dx.doi.org/10.1371/journal.pmed.0030400 Text en © 2006 Kronmal et al. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited. |
spellingShingle | Research Article Kronmal, Richard A Barzilay, Joshua I Smith, Nicholas L Psaty, Bruce M Kuller, Lewis H Burke, Gregory L Furberg, Curt Mortality in Pharmacologically Treated Older Adults with Diabetes: The Cardiovascular Health Study, 1989–2001 |
title | Mortality in Pharmacologically Treated Older Adults with Diabetes: The Cardiovascular Health Study, 1989–2001 |
title_full | Mortality in Pharmacologically Treated Older Adults with Diabetes: The Cardiovascular Health Study, 1989–2001 |
title_fullStr | Mortality in Pharmacologically Treated Older Adults with Diabetes: The Cardiovascular Health Study, 1989–2001 |
title_full_unstemmed | Mortality in Pharmacologically Treated Older Adults with Diabetes: The Cardiovascular Health Study, 1989–2001 |
title_short | Mortality in Pharmacologically Treated Older Adults with Diabetes: The Cardiovascular Health Study, 1989–2001 |
title_sort | mortality in pharmacologically treated older adults with diabetes: the cardiovascular health study, 1989–2001 |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1609124/ https://www.ncbi.nlm.nih.gov/pubmed/17048978 http://dx.doi.org/10.1371/journal.pmed.0030400 |
work_keys_str_mv | AT kronmalricharda mortalityinpharmacologicallytreatedolderadultswithdiabetesthecardiovascularhealthstudy19892001 AT barzilayjoshuai mortalityinpharmacologicallytreatedolderadultswithdiabetesthecardiovascularhealthstudy19892001 AT smithnicholasl mortalityinpharmacologicallytreatedolderadultswithdiabetesthecardiovascularhealthstudy19892001 AT psatybrucem mortalityinpharmacologicallytreatedolderadultswithdiabetesthecardiovascularhealthstudy19892001 AT kullerlewish mortalityinpharmacologicallytreatedolderadultswithdiabetesthecardiovascularhealthstudy19892001 AT burkegregoryl mortalityinpharmacologicallytreatedolderadultswithdiabetesthecardiovascularhealthstudy19892001 AT furbergcurt mortalityinpharmacologicallytreatedolderadultswithdiabetesthecardiovascularhealthstudy19892001 |